4.8 Article

Nuclear UHRF1 is a gate-keeper of cellular AMPK activity and function

Journal

CELL RESEARCH
Volume 32, Issue 1, Pages 54-71

Publisher

SPRINGERNATURE
DOI: 10.1038/s41422-021-00565-y

Keywords

-

Categories

Funding

  1. Ministry of Science and Technology of China [2017YFA054201]
  2. National Natural Science Foundation of China [91957120, 31730048, 31961133009]
  3. Shanghai Science and Technology Committee [20JC1411500]

Ask authors/readers for more resources

The study reveals that UHRF1 acts as a novel gate-keeper of AMPK, regulating cellular energy metabolism and playing critical roles in glucose and lipid metabolism.
The AMP-activated protein kinase (AMPK) is a central regulator of energy homeostasis. Although much has been learned on how low energy status and glucose starvation activate AMPK, how AMPK activity is properly controlled in vivo is still poorly understood. Here we report that UHRF1, an epigenetic regulator highly expressed in proliferating and cancer cells, interacts with AMPK and serves to suppress AMPK activity under both basal and stressed conditions. As a nuclear protein, UHRF1 promotes AMPK nuclear retention and strongly suppresses nuclear AMPK activity toward substrates H2B and EZH2. Importantly, we demonstrate that UHRF1 also robustly inhibits AMPK activity in the cytoplasm compartment, most likely as a consequence of AMPK nucleocytoplasmic shuttling. Mechanistically, we found that UHRF1 has no obvious effect on AMPK activation by upstream kinases LKB1 and CAMKK2 but inhibits AMPK activity by acting as a bridging factor targeting phosphatase PP2A to dephosphorylate AMPK. Hepatic overexpression of UHRF1 showed profound effects on glucose and lipid metabolism in wild-type mice but not in those with the liver-specific knockout of AMPK alpha 1/alpha 2, whereas knockdown of UHRF1 in adipose tissue led to AMPK activation and reduced sizes of adipocytes and lipogenic activity, highlighting the physiological significance of this regulation in glucose and lipid metabolism. Thus, our study identifies UHRF1 as a novel AMPK gate-keeper with critical roles in cellular metabolism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

PINK1 kinase dysfunction triggers neurodegeneration in the primate brain without impacting mitochondrial homeostasis

Weili Yang, Xiangyu Guo, Zhuchi Tu, Xiusheng Chen, Rui Han, Yanting Liu, Sen Yan, Qi Wang, Zhifu Wang, Xianxian Zhao, Yunpeng Zhang, Xin Xiong, Huiming Yang, Peng Yin, Huida Wan, Xingxing Chen, Jifeng Guo, Xiao-Xin Yan, Lujian Liao, Shihua Li, Xiao-Jiang Li

Summary: Research indicates that the kinase form of PINK1 is selectively expressed in human and monkey brains, causing neurodegeneration when deficient, without affecting mitochondrial protein expression and morphology. Mutations in PINK1 reduce protein phosphorylation crucial for neuronal survival, suggesting that its kinase activity is essential for primate brain function, potentially implicating kinase dysfunction in the pathogenesis of Parkinson's disease.

PROTEIN & CELL (2022)

Article Multidisciplinary Sciences

Class I histone deacetylases (HDAC1-3) are histone lysine delactylases

Carlos Moreno-Yruela, Di Zhang, Wei Wei, Michael Baek, Wenchao Liu, Jinjun Gao, Daniela Dankova, Alexander L. Nielsen, Julie E. Bolding, Lu Yang, Samuel T. Jameson, Jiemin Wong, Christian A. Olsen, Yingming Zhao

Summary: Lysine L-lactylation is a newly discovered histone modification that is stimulated under conditions of high glycolysis. Through systematic evaluation of histone deacetylases (HDACs), HDAC1-3 and SIRT1-3 were identified as delactylases for this modification. This study provides important insights into the regulatory mechanisms of histone lactylation.

SCIENCE ADVANCES (2022)

Article Biochemistry & Molecular Biology

Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis

Bin Jiang, Jia Zhang, Guohui Zhao, Mengjue Liu, Jielu Hu, Furong Lin, Jinyang Wang, Wentao Zhao, Huanhuan Ma, Cixiong Zhang, Caiming Wu, Luming Yao, Qingfeng Liu, Xin Chen, Yating Cao, Yi Zheng, Chensong Zhang, Aidong Han, Donghai Lin, Qinxi Li

Summary: GLS1 promotes cell proliferation when glutamine is abundant, but facilitates apoptosis when glutamine is deprived. Under glutamine deprivation, GLS1 forms filamentous polymers with enhanced catalytic activity, depleting intracellular glutamine.

MOLECULAR CELL (2022)

Article Biochemistry & Molecular Biology

Metabolic reprogramming in astrocytes results in neuronal dysfunction in intellectual disability

Haibin Zhang, Qiuyang Zheng, Tiantian Guo, Shijun Zhang, Shuang Zheng, Ruimin Wang, Qingfang Deng, Guowei Yang, Shuo Zhang, Linxin Tang, Qiuping Qi, Lin Zhu, Xiu-Fang Zhang, Hong Luo, Xian Zhang, Hao Sun, Yue Gao, Hongfeng Zhang, Ying Zhou, Aidong Han, Chen-Song Zhang, Huaxi Xu, Xin Wang

Summary: This study reveals the role of astrocytic metabolic dysregulation in neuronal dysfunction in intellectual disability and suggests a strategy for treating intellectual disability by restoring astrocytic metabolic function.

MOLECULAR PSYCHIATRY (2022)

Article Biology

Identification of serum metabolites enhancing inflammatory responses in COVID-19

Chen-Song Zhang, Bingchang Zhang, Mengqi Li, Xiaoyan Wei, Kai Gong, Zhiyong Li, Xiangyang Yao, Jianfeng Wu, Cixiong Zhang, Mingxia Zhu, Lei Zhang, Xiufeng Sun, Yi-Hong Zhan, Zhengye Jiang, Wenpeng Zhao, Wei Zhong, Xinguo Zhuang, Dawang Zhou, Hai-Long Piao, Sheng-Cai Lin, Zhanxiang Wang

Summary: By analyzing the serum metabolome and lipidome in COVID-19 patients at different stages, we identified significant alterations in 611 metabolites. Among them, agmatine and putrescine were prominently elevated, while 2-quinolinecarboxylate showed a biphasic change. These metabolites were found to activate the NF-kappa B pathway and induce strong proinflammatory cytokine production. Interestingly, they had limited effects on interferon production. These findings may provide insights for the development of drugs to alleviate inflammation in COVID-19 patients.

SCIENCE CHINA-LIFE SCIENCES (2022)

Article Cell Biology

Midkine noncanonically suppresses AMPK activation through disrupting the LKB1-STRAD-Mo25 complex

Tian Xia, Di Chen, Xiaolong Liu, Huan Qi, Wen Wang, Huan Chen, Ting Ling, Wuxiyar Otkur, Chen-Song Zhang, Jongchan Kim, Sheng-Cai Lin, Hai-long Piao

Summary: In this study, it was found that intracellular MDK interacts with LKB1 and STRAD, leading to the disruption of the LKB1-STRAD-Mo25 complex. As a result, the activity of LKB1 is decreased, dampening the activation of AMPK. Additionally, MDK expression is significantly upregulated in liver, kidney, and breast cancers, and is inversely correlated with phosphorylated AMPK levels.

CELL DEATH & DISEASE (2022)

Article Plant Sciences

Label-Free Quantitative Proteomics Unravel the Impacts of Salt Stress on Dendrobium huoshanense

Cheng Song, Yunpeng Zhang, Rui Chen, Fucheng Zhu, Peipei Wei, Haoyu Pan, Cunwu Chen, Jun Dai

Summary: This study identified differentially expressed proteins in Dendrobium huoshanense, revealing the enrichment of proteins involved in vitamin B6 metabolism, photosynthesis, spliceosome, arginine biosynthesis, oxidative phosphorylation, and MAPK signaling. Peroxidases and antioxidant enzymes were also identified.

FRONTIERS IN PLANT SCIENCE (2022)

Article Pharmacology & Pharmacy

Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer

Juanjuan Feng, Zhengke Lian, Xinting Xia, Yue Lu, Kewen Hu, Yunpeng Zhang, Yanan Liu, Longmiao Hu, Kun Yuan, Zhenliang Sun, Xiufeng Pang

Summary: It is found that KRAS-mutant non-small cell lung cancer (NSCLC) is resistant to MEK inhibitors due to the activation of mitochondrial oxidative phosphorylation (OX-PHOS), and the co-administration of trametinib and IACS-010759 can effectively inhibit tumor growth and prolong mouse survival.

ACTA PHARMACEUTICA SINICA B (2023)

Article Biochemistry & Molecular Biology

AMPK directly phosphorylates TBK1 to integrate glucose sensing into innate immunity

Qian Zhang, Shengduo Liu, Chen-Song Zhang, Qirou Wu, Xinyuan Yu, Ruyuan Zhou, Fansen Meng, Ailian Wang, Fei Zhang, Shasha Chen, Xiaojian Wang, Lei Li, Jun Huang, Yao-Wei Huang, Jian Zou, Jun Qin, Tingbo Liang, Xin-Hua Feng, Sheng-Cai Lin, Pinglong Xu

Summary: This study found that viral infection leads to a rapid decrease in blood glucose levels, resulting in the activation of AMPK. The activated AMPK directly phosphorylates TBK1, triggering the recruitment of IRF3 and the assembly of MAVS or STING signalosomes. However, depletion or inhibition of AMPK and increased glucose levels impair nucleic acid sensing, while enhancing the AMPK-TBK1 cascade significantly improves antiviral immunity.

MOLECULAR CELL (2022)

Article Biochemistry & Molecular Biology

GSK3 beta-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma

Li Kang, Yujie Liu, Jianzhong He, Yaling Wang, Mengyang Xue, Xin Wu, Zhen Wang, Yunpeng Zhang, Manyu Chu, Jialun Li, Wei Wei, Jiwen Li, Enmin Li, Lujian Liao, Jianru Xiao, Rong Zhang, Liyan Xu, Jiemin Wong

Summary: By screening a small-molecule kinase inhibitor library, GSK3 ss was identified as a critical kinase for promoting the overexpression of SOX2 in ESCC. Inhibition of GSK3 ss selectively impaired the proliferation and stemness of SOX2-positive ESCC cells. Clinical studies also showed a positive correlation between GSK3 ss and SOX2 protein levels in esophageal tumors, indicating the potential of targeting GSK3 ss for the treatment of ESCC.

ONCOGENE (2023)

Article Multidisciplinary Sciences

Loss of PHF8 induces a viral mimicry response by activating endogenous retrotransposons

Yanan Liu, Longmiao Hu, Zhengzhen Wu, Kun Yuan, Guangliang Hong, Zhengke Lian, Juanjuan Feng, Na Li, Dali Li, Jiemin Wong, Jiekai Chen, Mingyao Liu, Jiangping He, Xiufeng Pang

Summary: Immunotherapy has become a major treatment modality for various solid tumors, including colorectal cancer. The study identifies PHF8 as an essential mediator of immune escape in colorectal cancer, and targeting PHF8 induces a viral mimicry response to enhance anti-tumor immunity.

NATURE COMMUNICATIONS (2023)

Article Cell Biology

Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate

Yu-Qing Wu, Chen-Song Zhang, Jinye Xiong, Dong-Qi Cai, Chen-Zhe Wang, Yu Wang, Yan-Hui Liu, Yu Wang, Yiming Li, Jian Wu, Jianfeng Wu, Bin Lan, Xuefeng Wang, Siwei Chen, Xianglei Cao, Xiaoyan Wei, Hui-Hui Hu, Huiling Guo, Yaxin Yu, Abdul Ghafoor, Changchuan Xie, Yaying Wu, Zheni Xu, Cixiong Zhang, Mingxia Zhu, Xi Huang, Xiufeng Sun, Shu-Yong Lin, Hai-Long Piao, Jianyin Zhou, Sheng-Cai Lin

Summary: This study uncovers a mechanism by which low levels of glycolytic metabolite 3-PGA can switch PHGDH from serine synthesis to pro-apoptotic activation of p53. The interaction between PHGDH and AXIN in complex with HIPK2 leads to the formation of a multivalent p53-binding complex, allowing HIPK2 to phosphorylate p53-Ser46 and promote apoptosis. Mutants of PHGDH that are unable to bind 3-PGA either abolish p53 activation or cause constitutive activation and apoptosis in HCC cells. Caloric restriction can impede HCC growth dependent on PHGDH by lowering whole-body glucose levels.

CELL RESEARCH (2023)

Article Endocrinology & Metabolism

The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK

Chen-Song Zhang, Mengqi Li, Yu Wang, Xiaoyang Li, Yue Zong, Shating Long, Mingliang Zhang, Jin-Wei Feng, Xiaoyan Wei, Yan-Hui Liu, Baoding Zhang, Jianfeng Wu, Cixiong Zhang, Wenhua Lian, Teng Ma, Xiao Tian, Qi Qu, Yaxin Yu, Jinye Xiong, Dong-Tai Liu, Zhenhua Wu, Mingxia Zhu, Changchuan Xie, Yaying Wu, Zheni Xu, Chunyan Yang, Junjie Chen, Guohong Huang, Qingxia He, Xi Huang, Lei Zhang, Xiufeng Sun, Qingfeng Liu, Abdul Ghafoor, Fu Gui, Kaili Zheng, Wen Wang, Zhi-Chao Wang, Yong Yu, Qingliang Zhao, Shu-Yong Lin, Zhi-Xin Wang, Hai-Long Piao, Xianming Deng, Sheng-Cai Lin

Summary: A small-molecule aldolase inhibitor, aldometanib, is reported to selectively activate the lysosomal pool of AMPK, leading to glucose-lowering effects. This compound mimics the cellular state of glucose starvation and shows potential as a therapeutic for metabolic disorders in humans.

NATURE METABOLISM (2022)

No Data Available